Diagnosis and Treatment of Viral Myocarditis

Overview

Journal Mayo Clin Proc

Specialty General Medicine

Date 2009 Nov 3

PMID 19880690

Citations 101

Authors

Jason C Schultz

Anthony A Hilliard

Leslie T Cooper Jr

Charanjit S Rihal

Affiliations

Soon will be listed here.

Abstract

Myocarditis, an inflammatory disease of heart muscle, is an important cause of dilated cardiomyopathy worldwide. Viral infection is also an important cause of myocarditis, and the spectrum of viruses known to cause myocarditis has changed in the past 2 decades. Several new diagnostic methods, such as cardiac magnetic resonance imaging, are useful for diagnosing myocarditis. Endomyocardial biopsy may be used for patients with acute dilated cardiomyopathy associated with hemodynamic compromise, those with life-threatening arrhythmia, and those whose condition does not respond to conventional supportive therapy. Important prognostic variables include the degree of left and right ventricular dysfunction, heart block, and specific histopathological forms of myocarditis. We review diagnostic and therapeutic strategies for the treatment of viral myocarditis. English-language publications in PubMed and references from relevant articles published between January 1, 1985, and August 5, 2008, were analyzed. Main keywords searched were myocarditis, dilated cardiomyopathy, endomyocardial biopsy, cardiac magnetic resonance imaging, and immunotherapy.

Citing Articles

Effect of Astragalus injection treatment for viral myocarditis: a systematic review and meta-analysis.

Jialiken D, Qian L, Wen S, Ren S, Fan Y, Dong Y Eur J Med Res. 2025; 30(1):1.

PMID: 39754214 PMC: 11697883. DOI: 10.1186/s40001-024-02193-9.

Three modes of viral adaption by the heart.

Griffiths C, Shah M, Shao W, Borgman C, Janes K Sci Adv. 2024; 10(46):eadp6303.

PMID: 39536108 PMC: 11559625. DOI: 10.1126/sciadv.adp6303.

GPR15-mediated T cell recruitment during acute viral myocarditis facilitated virus elimination and improved outcome.

Stoffers B, Wolf H, Bacmeister L, Kupsch S, Vico T, Marchini T Nat Cardiovasc Res. 2024; 3(1):76-93.

PMID: 39195892 PMC: 11357984. DOI: 10.1038/s44161-023-00401-z.

Soluble suppression of tumorigenicity 2 associated with major adverse cardiac events in children with myocarditis.

Shi T, Ge J, Li S, Zhang Y Front Cardiovasc Med. 2024; 11:1404432.

PMID: 38807947 PMC: 11130408. DOI: 10.3389/fcvm.2024.1404432.

Enhancing the implantation of mechanical circulatory support devices using computational simulations.

Lopez-Santana G, De Rosis A, Grant S, Venkateswaran R, Keshmiri A Front Bioeng Biotechnol. 2024; 12:1279268.

PMID: 38737533 PMC: 11084291. DOI: 10.3389/fbioe.2024.1279268.

References

Heart Failure Society Of America . HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006; 12(1):e1-2. DOI: 10.1016/j.cardfail.2005.11.005. View

Friedrich M, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper L . Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53(17):1475-87. PMC: 2743893. DOI: 10.1016/j.jacc.2009.02.007. View

Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T . Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001; 104(1):39-45. DOI: 10.1161/01.cir.104.1.39. View

Chen Y, Wang M, Chou N, Han Y, Chiu I, Lin F . Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation. Ann Thorac Surg. 2000; 68(6):2220-4. DOI: 10.1016/s0003-4975(99)01174-1. View

Maron B, Ackerman M, Nishimura R, Pyeritz R, Towbin J, Udelson J . Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005; 45(8):1340-5. DOI: 10.1016/j.jacc.2005.02.011. View

Chang A, Hanley F, Weindling S, Wernovsky G, Wessel D . Left heart support with a ventricular assist device in an infant with acute myocarditis. Crit Care Med. 1992; 20(5):712-5. DOI: 10.1097/00003246-199205000-00028. View

Magnani J, Danik H, Dec Jr G, DiSalvo T . Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J. 2006; 151(2):463-70. DOI: 10.1016/j.ahj.2005.03.037. View

Frustaci A, Russo M, Chimenti C . Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009; 30(16):1995-2002. DOI: 10.1093/eurheartj/ehp249. View

Skouri H, Dec G, Friedrich M, Cooper L . Noninvasive imaging in myocarditis. J Am Coll Cardiol. 2006; 48(10):2085-93. DOI: 10.1016/j.jacc.2006.08.017. View

10.

Mason J, OConnell J, Herskowitz A, Rose N, McManus B, Billingham M . A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995; 333(5):269-75. DOI: 10.1056/NEJM199508033330501. View

11.

Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S . Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994; 72(6):561-6. PMC: 1025643. DOI: 10.1136/hrt.72.6.561. View

12.

Baughman K . Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006; 113(4):593-5. DOI: 10.1161/CIRCULATIONAHA.105.589663. View

13.

Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T . Predictors of outcome in patients with suspected myocarditis. Circulation. 2008; 118(6):639-48. DOI: 10.1161/CIRCULATIONAHA.108.769489. View

14.

Yelgec N, Dymarkowski S, Ganame J, Bogaert J . Value of MRI in patients with a clinical suspicion of acute myocarditis. Eur Radiol. 2007; 17(9):2211-7. DOI: 10.1007/s00330-007-0612-3. View

15.

Lee C, Tsai W, Hsu C, Liu P, Lin L, Chen J . Predictive factors of a fulminant course in acute myocarditis. Int J Cardiol. 2006; 109(1):142-5. DOI: 10.1016/j.ijcard.2005.04.014. View

16.

Stanton C, Mookadam F, Cha S, McNamara D, Aukrust P, Wojnicz R . Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. Int J Cardiol. 2007; 128(1):38-41. DOI: 10.1016/j.ijcard.2007.05.016. View

17.

Bowles N, Ni J, Kearney D, Pauschinger M, Schultheiss H, McCarthy R . Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003; 42(3):466-72. DOI: 10.1016/s0735-1097(03)00648-x. View

18.

Cooper L . The heat is off: immunosuppression for myocarditis revisited. Eur Heart J. 2009; 30(16):1936-9. DOI: 10.1093/eurheartj/ehp172. View

19.

Cooper L, Baughman K, Feldman A, Frustaci A, Jessup M, Kuhl U . The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure.... Eur Heart J. 2007; 28(24):3076-93. DOI: 10.1093/eurheartj/ehm456. View

20.

HUFNAGEL G, Pankuweit S, Richter A, Schonian U, Maisch B . The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz. 2000; 25(3):279-85. DOI: 10.1007/s000590050021. View